Sunshine anti-cancer drug advances to next stage trials
11:52 EDT 17 Sep 2012 | Pharmaceutical Business Review
Sunshine Biopharma said its anti-cancer compound, Adva-27a, has advanced to the next phase of drug development, namely GMP manufacturing, IND-enabling studies and Phase I clinical trials in humans.
Original Article: Sunshine anti-cancer drug advances to next stage trials
More From BioPortfolio on "Sunshine anti-cancer drug advances to next stage trials"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
